CVE-2025-54817A reflected cross-site scripting (xss) vulnerability exists in the autoPurge functionality of MedDream PACS Premium 7.3.6.870.
Updated under an hour ago ()
Does this affect you?
It affects MedDream PACS Premium and 1 other product. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.36%, higher than 28% of scored CVEs.
Do this next
Free account, 1 product
A reflected cross-site scripting (xss) vulnerability exists in the autoPurge functionality of MedDream PACS Premium 7.3.6.870. A specially crafted malicious url can lead to arbitrary javascript code execution. An attacker can provide a URL to a malicious website to trigger this vulnerability.
- CVSS
- 6.1 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
- Weakness (CWE)
- CWE-79
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.36% (percentile 28)
- Assigned by
- talos
- NVD analysis
- Analyzed
- Record last updated
- Jan 21, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
MedDream MedDream PACS Premium meddream:pacs_premium (from the name) | 7.3.6.870 | CNA record |
meddream pacs_server meddream:pacs_server | 7.3.6.870 | NVD |
References
- https://talosintelligence.com/vulnerability_reports/TALOS-2025-2253exploit, third-party-advisory
- https://www.talosintelligence.com/vulnerability_reports/TALOS-2025-2253exploit, third-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.